(Q44531911)

3 December 2017

title

Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant (English)

1 reference

3 December 2017

1 reference

5

Arne Kolstad

1 reference

3 December 2017

Niels S Andersen

1

1 reference

3 December 2017

Lone Pedersen

2

1 reference

3 December 2017

Erkki Elonen

3

1 reference

3 December 2017

Anna Johnson

4

1 reference

3 December 2017

Kaarle Franssila

6

1 reference

3 December 2017

Ruth Langholm

7

1 reference

3 December 2017

Elisabeth Ralfkiaer

8

1 reference

3 December 2017

Måns Akerman

9

1 reference

3 December 2017

Mikael Eriksson

10

1 reference

3 December 2017

Outi Kuittinen

11

1 reference

3 December 2017

Christian H Geisler

12

1 reference

3 December 2017

Nordic Lymphoma Group

13

1 reference

3 December 2017

language of work or name

1 reference

1 August 2003

1 reference

European Journal of Haematology

3 December 2017

published in

1 reference

3 December 2017

volume

71

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

73-80

1 reference

Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

7 January 2021

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

7 January 2021

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

7 January 2021

Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

7 January 2021

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00093.X

7 January 2021

10.1034/J.1600-0609.2003.00093.X

Identifiers

DOI

1 reference

3 December 2017

1 reference